Showing 1 - 4 of 4 Items
Showing 1 - 4 of 4 Items
Sort By: Relevance
Journal Article
|Research
2011-04-19 • Lancet
2011-04-19 • Lancet
BACKGROUND: The Xpert MTB/RIF test (Cepheid, Sunnyvale, CA, USA) can detect tuberculosis and its multidrug-resistant form with very high sensitivity and specificity in controlled studies...
Journal Article
|Research
2014-11-25 • PLOS Medicine
2014-11-25 • PLOS Medicine
BACKGROUND
Xpert MTB/RIF is approved for use in tuberculosis (TB) and rifampicin-resistance diagnosis. However, data are limited on the impact of Xpert under routine conditions in se...
Xpert MTB/RIF is approved for use in tuberculosis (TB) and rifampicin-resistance diagnosis. However, data are limited on the impact of Xpert under routine conditions in se...
Journal Article
|Commentary
2017-11-11 • Lancet
2017-11-11 • Lancet
Diagnostics are crucial in mitigating the effect of disease outbreaks. Because diagnostic development and validation are time consuming, they should be carried out in anticipation of epi...
Journal Article
|Short Report
2015-04-01 • Journal of Infectious Diseases
2015-04-01 • Journal of Infectious Diseases
To accelerate the fight against tuberculosis, major diagnostic challenges need to be addressed urgently. Post-2015 targets are unlikely to be met without the use of novel diagnostics tha...